8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 13, 2026·SEC
Material company update
Apr 1, 2026·SEC
Merit Medical Systems, Inc.(MMSI)Earnings, Financials & Key Ratios
MMSI•NASDAQ
31.6× P/E·Price updated Jun 19, 2026
AboutMerit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.Show more
- Revenue$1.51B+11.7%
- EBITDA$319M+18.0%
- Net Income$128M+6.8%
- EPS (Diluted)2.13+4.9%
- Gross Margin48.65%+2.6%
- EBITDA Margin21.06%+5.6%
- Operating Margin12.17%+6.1%
- Net Margin8.48%-4.4%
- ROE8.67%-7.0%
MMSI Key Insights
Merit Medical Systems, Inc. (MMSI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when MMSI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MMSI Price & Volume
Merit Medical Systems, Inc. (MMSI) stock price & volume — 10-year historical chart
Loading chart...
MMSI Growth Metrics
Merit Medical Systems, Inc. (MMSI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years10.82%
5 Years9.46%
3 Years9.59%
TTM11.17%
Profit CAGR
10 Years18.37%
5 Years-
3 Years19.91%
TTM13.96%
EPS CAGR
10 Years14.92%
5 Years-
3 Years18.19%
TTM13.24%
Return on Capital
10 Years4.62%
5 Years6.49%
3 Years7.36%
Last Year7.93%
MMSI Recent Earnings
Merit Medical Systems, Inc. (MMSI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$0.94+11.9%
$0.84
Rev
$382M+1.1%
$378M
Q1 2026
Feb 24, 2026Metric
Actual
Est
EPS
$1.04+8.3%
$0.96
Rev
$394M+1.0%
$390M
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$0.92+12.2%
$0.82
Rev
$384M-1.1%
$388M
Q3 2025
Jul 30, 2025Metric
Actual
Est
EPS
$1.01+17.4%
$0.86
Rev
$382M+3.0%
$371M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.94vs $0.84+11.9% | $382Mvs $378M+1.1% |
| Q1 2026 | Feb 24, 2026 | $1.04vs $0.96+8.3% | $394Mvs $390M+1.0% |
| Q4 2025 | Oct 30, 2025 | $0.92vs $0.82+12.2% | $384Mvs $388M-1.1% |
| Q3 2025 | Jul 30, 2025 | $1.01vs $0.86+17.4% | $382Mvs $371M+3.0% |
Based on last 12 quarters of dataView full earnings history →
MMSI Peer Comparison
Merit Medical Systems, Inc. (MMSI) competitors in Surgical and interventional devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ITGR | 3.13B | 90.96 | 31.47 | 7.57% | 7.67% | 8.23% | 0.80 | |
 NNOX | 109.19M | 1.67 | -1.84 | 13.91% | -452.82% | -35.55% | 0.04 | |
 ATRC | 1.46B | 28.80 | -120 | 14.88% | -0.83% | -0.95% | 0.18 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 ANGO | 505.13M | 12.15 | -14.64 | -3.76% | -9.02% | -15.71% | ||
 BSX | 67.31B | 45.29 | 23.35 | 19.87% | 14.4% | 12.4% | 0.51 | |
 BDX | 52.16B | 143.98 | 24.70 | 8.23% | 5.33% | 4.54% | 0.76 |
Compare MMSI vs Peers
Merit Medical Systems, Inc. (MMSI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MMSI Income Statement
Merit Medical Systems, Inc. (MMSI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 727.85M | 882.75M | 994.85M | 963.88M | 1.07B | 1.15B | 1.26B | 1.36B | 1.51B | 1.54B |
Revenue Growth % | 20.54% | 21.28% | 12.7% | -3.11% | 11.5% | 7.09% | 9.24% | 7.89% | 11.66% | 11.17% |
Cost of Goods Sold | 401.6M | 487.98M | 562.49M | 562.7M | 589.42M | 631.88M | 673.49M | 713.18M | 777.79M | 791.29M |
COGS % of Revenue | 55.18% | 55.28% | 56.54% | 58.38% | 54.84% | 54.9% | 53.56% | 52.57% | 51.35% | - |
Gross Profit | 326.25M▲ 0% | 394.77M▲ 21.0% | 432.37M▲ 9.5% | 401.18M▼ 7.2% | 485.33M▲ 21.0% | 519.1M▲ 7.0% | 583.87M▲ 12.5% | 643.33M▲ 10.2% | 736.94M▲ 14.6% | 750.98M▲ 0% |
Gross Margin % | 44.82% | 44.72% | 43.46% | 41.62% | 45.16% | 45.1% | 46.44% | 47.43% | 48.65% | 48.69% |
Gross Profit Growth % | 23.1% | 21% | 9.52% | -7.21% | 20.98% | 6.96% | 12.48% | 10.18% | 14.55% | - |
Operating Expenses | 280.54M | 335.55M | 416.93M | 402.74M | 424.42M | 431.54M | 458.73M | 487.64M | 552.57M | 563.42M |
OpEx % of Revenue | 38.54% | 38.01% | 41.91% | 41.78% | 39.49% | 37.49% | 36.48% | 35.95% | 36.48% | - |
Selling, General & Admin | 229.13M | 276.02M | 327.27M | 297.72M | 335.69M | 342.52M | 373.68M | 376.73M | 455.21M | 465.94M |
SG&A % of Revenue | 31.48% | 31.27% | 32.9% | 30.89% | 31.23% | 29.76% | 29.72% | 27.77% | 30.05% | - |
Research & Development | 51.4M | 59.53M | 65.61M | 57.54M | 71.25M | 75.51M | 82.73M | 83.81M | 97.35M | 97.48M |
R&D % of Revenue | 7.06% | 6.74% | 6.6% | 5.97% | 6.63% | 6.56% | 6.58% | 6.18% | 6.43% | - |
Other Operating Expenses | -872K | 63K | 24.04M | 47.48M | 17.48M | 13.5M | 3.52M | 27.09M | 0 | 0 |
Operating Income | 33.07M▲ 0% | 58.62M▲ 77.3% | 15.43M▼ 73.7% | -1.56M▼ 110.1% | 60.92M▲ 3999.9% | 87.56M▲ 43.7% | 123.94M▲ 41.5% | 155.69M▲ 25.6% | 184.38M▲ 18.4% | 187.74M▲ 0% |
Operating Margin % | 4.54% | 6.64% | 1.55% | -0.16% | 5.67% | 7.61% | 9.86% | 11.48% | 12.17% | 12.17% |
Operating Income Growth % | -5.18% | 77.26% | -73.67% | -110.12% | 3999.87% | 43.74% | 41.55% | 25.62% | 18.42% | - |
EBITDA | 86.65M | 128.16M | 119.79M | 105.25M | 156.7M | 179.76M | 225.24M | 270.43M | 319.03M | 290.11M |
EBITDA Margin % | 11.91% | 14.52% | 12.04% | 10.92% | 14.58% | 15.62% | 17.91% | 19.94% | 21.06% | 18.81% |
EBITDA Growth % | 10.2% | 47.91% | -6.53% | -12.13% | 48.88% | 14.72% | 25.3% | 20.06% | 17.97% | -0.24% |
D&A (Non-Cash Add-back) | 53.58M | 69.55M | 104.36M | 106.82M | 95.78M | 92.2M | 101.29M | 114.73M | 134.65M | 102.37M |
EBIT | 43.62M | 59.88M | 14.9M | -3.24M | 59.18M | 88.97M | 127.6M | 159.24M | 184.38M | 143.58M |
Net Interest Income | -7.36M | -9.16M | -12.7M | -9.39M | -4.49M | -5.9M | -13.05M | -4.99M | -11.39M | -8.61M |
Interest Income | 381K | 1.2M | 0 | 604K | 769K | 439K | 2.46M | 26.23M | 15.07M | 15.18M |
Interest Expense | 7.74M | 10.36M | 12.7M | 9.99M | 5.26M | 6.34M | 15.51M | 31.22M | 26.46M | 13.37M |
Other Income/Expense | 2.81M | -9.1M | -13.24M | -11.67M | -7M | -4.93M | -11.86M | -5.7M | -13.44M | -1.22M |
Pretax Income | 35.88M▲ 0% | 49.52M▲ 38.0% | 2.19M▼ 95.6% | -13.23M▼ 703.3% | 53.92M▲ 507.5% | 82.63M▲ 53.3% | 112.09M▲ 35.7% | 149.99M▲ 33.8% | 170.94M▲ 14.0% | 186.53M▲ 0% |
Pretax Margin % | 4.93% | 5.61% | 0.22% | -1.37% | 5.02% | 7.18% | 8.91% | 11.06% | 11.29% | 12.09% |
Income Tax | 8.36M | 7.5M | -3.26M | -3.39M | 5.46M | 8.11M | 17.68M | 29.64M | 42.45M | 47.19M |
Effective Tax Rate % | 23.29% | 15.15% | -148.56% | 25.61% | 10.13% | 9.82% | 15.77% | 19.76% | 24.83% | 25.3% |
Net Income | 27.52M▲ 0% | 42.02M▲ 52.7% | 5.45M▼ 87.0% | -9.84M▼ 280.6% | 48.45M▲ 592.3% | 74.52M▲ 53.8% | 94.41M▲ 26.7% | 120.36M▲ 27.5% | 128.49M▲ 6.8% | 139.34M▲ 0% |
Net Margin % | 3.78% | 4.76% | 0.55% | -1.02% | 4.51% | 6.47% | 7.51% | 8.87% | 8.48% | 9.03% |
Net Income Growth % | 36.79% | 52.66% | -87.03% | -280.57% | 592.27% | 53.79% | 26.7% | 27.48% | 6.76% | 13.96% |
Net Income (Continuing) | 27.52M | 42.02M | 5.45M | -9.84M | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M | 139.34M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.55▲ 0% | 0.78▲ 41.8% | 0.10▼ 87.6% | -0.18▼ 285.8% | 0.84▲ 566.7% | 1.29▲ 53.6% | 1.62▲ 25.6% | 2.03▲ 25.3% | 2.13▲ 4.9% | 2.32▲ 0% |
EPS Growth % | 22.22% | 41.82% | -87.58% | -285.76% | 566.67% | 53.57% | 25.58% | 25.31% | 4.93% | 13.24% |
EPS (Basic) | 0.56 | 0.80 | 0.10 | -0.18 | 0.86 | 1.31 | 1.64 | 2.07 | 2.17 | - |
Diluted Shares Outstanding | 50.1M | 53.93M | 56.23M | 55.43M | 57.36M | 57.67M | 58.36M | 59.37M | 60.46M | 60.01M |
Basic Shares Outstanding | 48.8M | 52.27M | 55.08M | 55.43M | 56.15M | 56.81M | 57.59M | 58.22M | 59.16M | 59.51M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
MMSI Balance Sheet
Merit Medical Systems, Inc. (MMSI) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 316.12M | 429.83M | 454.54M | 429.71M | 482.21M | 529.08M | 1.11B | 923.77M | 1.04B | 1.1B |
Cash & Short-Term Investments | 32.34M | 67.36M | 44.32M | 56.92M | 67.75M | 58.41M | 589.14M | 376.71M | 448.5M | 488.08M |
Cash Only | 32.34M | 67.36M | 44.32M | 56.92M | 67.75M | 58.41M | 587.04M | 376.71M | 448.5M | 488.08M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2.1M | 0 | 0 | 0 |
Accounts Receivable | 116.18M | 149.99M | 168.53M | 157.96M | 172.84M | 178.45M | 189.26M | 209.17M | 223.61M | 227M |
Days Sales Outstanding | 58.26 | 62.02 | 61.83 | 59.82 | 58.7 | 56.59 | 54.94 | 56.28 | 53.88 | 53.63 |
Inventory | 155.29M | 197.54M | 225.7M | 198.02M | 221.92M | 265.99M | 303.87M | 306.06M | 333.7M | 352.39M |
Days Inventory Outstanding | 141.14 | 147.75 | 146.46 | 128.45 | 137.43 | 153.65 | 164.68 | 156.64 | 156.6 | 154.06 |
Other Current Assets | 0 | 11.33M | 12.5M | 13.12M | 16.15M | 22.32M | 22.19M | 28.54M | 29.39M | 34.31M |
Total Non-Current Assets | 795.69M | 1.19B | 1.3B | 1.23B | 1.17B | 1.13B | 1.22B | 1.49B | 1.65B | 1.62B |
Property, Plant & Equipment | 292.82M | 331.45M | 459.03M | 460.97M | 437.57M | 448.24M | 446.57M | 451.67M | 516M | 520.33M |
Fixed Asset Turnover | 2.49x | 2.66x | 2.17x | 2.09x | 2.46x | 2.57x | 2.82x | 3.00x | 2.94x | 3.02x |
Goodwill | 238.15M | 335.43M | 353.19M | 363.53M | 361.74M | 359.82M | 382.24M | 463.51M | 506.84M | 503.43M |
Intangible Assets | 227.32M | 462.71M | 445.31M | 367.92M | 319.27M | 275.87M | 325.88M | 498.26M | 537.65M | 512M |
Long-Term Investments | 5.75M | 5.92M | 17.13M | 12.04M | 14.71M | 15.58M | 19.06M | 22.83M | 45.66M | 93.46M |
Other Non-Current Assets | 29.29M | 51.66M | 24.33M | 25.63M | 26.71M | 28.78M | 35.73M | 42.5M | 32.57M | 74.67M |
Total Assets | 1.11B▲ 0% | 1.62B▲ 45.7% | 1.76B▲ 8.5% | 1.66B▼ 5.3% | 1.65B▼ 1.0% | 1.66B▲ 1.0% | 2.33B▲ 39.7% | 2.42B▲ 4.0% | 2.69B▲ 11.1% | 2.72B▲ 0% |
Asset Turnover | 0.65x | 0.54x | 0.57x | 0.58x | 0.65x | 0.69x | 0.54x | 0.56x | 0.56x | 0.58x |
Asset Growth % | 17.93% | 45.71% | 8.48% | -5.29% | -0.97% | 0.95% | 39.74% | 4.01% | 11.05% | 40.9% |
Total Current Liabilities | 115.62M | 175.34M | 181.66M | 185M | 236.28M | 220.65M | 203.56M | 216.4M | 239.76M | 216.87M |
Accounts Payable | 34.93M | 54.02M | 54.62M | 49.84M | 55.62M | 68.5M | 65.94M | 68.5M | 60.55M | 0 |
Days Payables Outstanding | 31.75 | 40.41 | 35.45 | 32.33 | 34.45 | 39.57 | 35.74 | 35.06 | 28.42 | 22.41 |
Short-Term Debt | 19.46M | 22M | 19.05M | 20.4M | 19.11M | 22.25M | 0 | 0 | 10.88M | 11.23M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 27.91M | 58.24M | 44.37M | 48.23M | 77.44M | 42.47M | 53.23M | 134.08M | 75.31M | 205.65M |
Current Ratio | 2.73x | 2.45x | 2.50x | 2.32x | 2.04x | 2.40x | 5.45x | 4.27x | 4.34x | 5.08x |
Quick Ratio | 1.39x | 1.32x | 1.26x | 1.25x | 1.10x | 1.19x | 3.95x | 2.85x | 2.95x | 3.46x |
Cash Conversion Cycle | 167.65 | 169.36 | 172.84 | 155.94 | 161.68 | 170.67 | 183.88 | 177.86 | 182.07 | 185.27 |
Total Non-Current Liabilities | 319.86M | 511.89M | 625.72M | 520.82M | 372.21M | 298.92M | 919.68M | 822.84M | 861.85M | 875.68M |
Long-Term Debt | 259.01M | 373.15M | 431.98M | 343.72M | 234.4M | 186.76M | 823.01M | 729.55M | 810.7M | 835.02M |
Capital Lease Obligations | 0 | 0 | 72.71M | 70.94M | 61.53M | 59.74M | 56.26M | 54.78M | 76.66M | 232.78M |
Deferred Tax Liabilities | 23.29M | 56.36M | 45.24M | 33.31M | 31.5M | 18.46M | 5.55M | 240K | 19.66M | 92.96M |
Other Non-Current Liabilities | 35.15M | 80.12M | 73.67M | 70.92M | 42.97M | 32.26M | 33.26M | 36.77M | -46.56M | 19.62M |
Total Liabilities | 435.48M | 687.24M | 807.38M | 705.82M | 608.5M | 519.57M | 1.12B | 1.04B | 1.1B | 1.09B |
Total Debt | 278.47M | 395.15M | 535.3M | 447.97M | 325.7M | 279.75M | 891.36M | 794.66M | 898.23M | 846.25M |
Net Debt | 246.14M | 327.79M | 490.98M | 391.05M | 257.95M | 221.35M | 304.32M | 417.95M | 449.73M | 358.17M |
Debt / Equity | 0.41x | 0.42x | 0.56x | 0.47x | 0.31x | 0.24x | 0.74x | 0.58x | 0.57x | 0.52x |
Debt / EBITDA | 3.21x | 3.08x | 4.47x | 4.26x | 2.08x | 1.56x | 3.96x | 2.94x | 2.82x | 2.92x |
Net Debt / EBITDA | 2.84x | 2.56x | 4.10x | 3.72x | 1.65x | 1.23x | 1.35x | 1.55x | 1.41x | 1.23x |
Interest Coverage | 5.64x | 5.78x | 1.17x | -0.32x | 11.25x | 14.04x | 8.23x | 5.10x | 6.97x | 10.74x |
Total Equity | 676.33M▲ 0% | 932.77M▲ 37.9% | 949.94M▲ 1.8% | 958.58M▲ 0.9% | 1.04B▲ 8.5% | 1.14B▲ 10.1% | 1.2B▲ 5.0% | 1.38B▲ 14.8% | 1.58B▲ 14.9% | 1.63B▲ 0% |
Equity Growth % | 35.76% | 37.92% | 1.84% | 0.91% | 8.47% | 10.06% | 5.03% | 14.76% | 14.86% | 60.34% |
Book Value per Share | 13.50 | 17.30 | 16.89 | 17.29 | 18.13 | 19.84 | 20.60 | 23.24 | 26.20 | 27.11 |
Total Shareholders' Equity | 676.33M | 932.77M | 949.94M | 958.58M | 1.04B | 1.14B | 1.2B | 1.38B | 1.58B | 1.63B |
Common Stock | 353.39M | 571.38M | 587.02M | 606.22M | 641.53M | 675.17M | 638.15M | 703.22M | 763.91M | 769.27M |
Retained Earnings | 321.41M | 363.43M | 368.22M | 357.8M | 406.26M | 480.77M | 575.18M | 695.54M | 824.03M | 865.02M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 1.53M | -2.03M | -5.29M | -5.45M | -7.99M | -11.55M | -11.33M | -19.4M | -3.64M | -7.57M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MMSI Cash Flow Statement
Merit Medical Systems, Inc. (MMSI) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 62.73M | 86.53M | 77.81M | 165.27M | 147.23M | 114.29M | 145.15M | 220.8M | 297.37M | 297.48M |
Operating CF Margin % | 8.62% | 9.8% | 7.82% | 17.15% | 13.7% | 9.93% | 11.54% | 16.28% | 19.63% | - |
Operating CF Growth % | 17.03% | 37.95% | -10.08% | 112.39% | -10.91% | -22.37% | 27% | 52.12% | 34.68% | 123.59% |
Net Income | 27.52M | 42.02M | 5.45M | -9.84M | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M | 139.34M |
Depreciation & Amortization | 53.58M | 69.55M | 104.36M | 106.82M | 95.78M | 92.2M | 101.29M | 114.73M | 134.65M | 135.72M |
Stock-Based Compensation | 4.08M | 6.12M | 9.38M | 14.34M | 16.09M | 18.04M | 21.33M | 28.47M | 43.46M | 43.34M |
Deferred Taxes | -1.3M | 2.05M | -12.44M | -11.29M | -4.63M | -14.92M | -12.64M | -14.87M | 5.21M | 5.21M |
Other Non-Cash Items | 3.05M | 2.75M | 26.79M | 31.02M | 9.37M | 15.86M | 10.78M | 9.05M | 8.9M | -36.25M |
Working Capital Changes | -24.2M | -35.94M | -55.73M | 34.24M | -17.84M | -71.4M | -70.02M | -36.95M | -23.34M | 10.12M |
Change in Receivables | -12.84M | -27.52M | -17.9M | 10.43M | -8.62M | -15.12M | 0 | -21.7M | -2.73M | 2.97M |
Change in Inventory | -17.83M | -28.17M | -27.04M | 29.43M | -25.18M | -47.93M | 0 | -2.29M | -21.6M | -11M |
Change in Payables | 417K | 15.73M | -2.29M | 333K | 6.05M | 12.66M | -7.3M | -2.31M | 1.01M | -3.44M |
Cash from Investing | -146.76M | -378.82M | -134.48M | -58.65M | -37.16M | -57.4M | -175.35M | -368.65M | -247.39M | -210.02M |
Capital Expenditures | -41.2M | -66.34M | -81.5M | -49.28M | -27.94M | -45.03M | -36.7M | 0 | 0 | -23.47M |
CapEx % of Revenue | 5.66% | 7.51% | 8.19% | 5.11% | 2.6% | 3.91% | 2.92% | 2.8% | 5.39% | 1.52% |
Acquisitions | -105.58M | -301.79M | -53.9M | -9.67M | -7.17M | -8.29M | -137.85M | -320.18M | -144.77M | -144.77M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 21K | -10.7M | 920K | 292K | -2.05M | -4.08M | -799K | -48.47M | -102.62M | -41.78M |
Cash from Financing | 96.52M | 328.28M | 33.53M | -95.71M | -98.44M | -60.26M | 559.27M | -60.01M | 16M | 2.75M |
Debt Issued (Net) | -46.42M | 116.5M | 44.5M | -88.38M | -108.5M | -44.94M | 619.58M | -99.06M | 0 | 0 |
Equity Issued (Net) | 143.81M | 214.99M | 6.25M | 6.63M | 21.31M | 20.07M | 15.58M | 40.91M | 28.21M | 15.06M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | -877K | -3.21M | -17.22M | -13.97M | -11.24M | -35.39M | -75.9M | -1.85M | -12.21M | -12.31M |
Net Change in Cash | 13.16M▲ 0% | 35.02M▲ 166.0% | -23.04M▼ 165.8% | 12.6M▲ 154.7% | 10.83M▼ 14.0% | -7.19M▼ 166.4% | 528.59M▲ 7449.6% | -210.38M▼ 139.8% | 69.78M▲ 133.2% | 92.65M▲ 0% |
Free Cash Flow | 21.53M▲ 0% | 20.2M▼ 6.2% | -3.68M▼ 118.2% | 115.99M▲ 3248.6% | 119.29M▲ 2.8% | 69.26M▼ 41.9% | 108.45M▲ 56.6% | 182.76M▲ 68.5% | 215.65M▲ 18.0% | 274.01M▲ 0% |
FCF Margin % | 2.96% | 2.29% | -0.37% | 12.03% | 11.1% | 6.02% | 8.63% | 13.47% | 14.24% | 17.77% |
FCF Growth % | 16.08% | -6.18% | -118.24% | 3248.59% | 2.84% | -41.94% | 56.58% | 68.52% | 18% | 53.82% |
FCF per Share | 0.43 | 0.37 | -0.07 | 2.09 | 2.08 | 1.20 | 1.86 | 3.08 | 3.57 | 4.57 |
FCF Conversion (FCF/Net Income) | 2.28x | 2.06x | 14.27x | -16.79x | 3.04x | 1.53x | 1.54x | 1.83x | 2.31x | 1.97x |
Interest Paid | 7.71M | 10.32M | 12.43M | 10.08M | 5.26M | 6.26M | 14.05M | 23.24M | 0 | 13.53M |
Taxes Paid | 6.05M | 8.69M | 12.07M | 8.92M | 8.83M | 17.09M | 31.53M | 45.05M | 0 | 19.54M |
MMSI Key Ratios
Merit Medical Systems, Inc. (MMSI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 4.69% | 5.22% | 0.58% | -1.03% | 4.85% | 6.82% | 8.05% | 9.33% | 8.67% | 8.95% |
Return on Invested Capital (ROIC) | 2.87% | 4.03% | 0.86% | -0.08% | 3.45% | 4.93% | 6.47% | 7.07% | 7.22% | 7.09% |
Gross Margin | 44.82% | 44.72% | 43.46% | 41.62% | 45.16% | 45.1% | 46.44% | 47.43% | 48.65% | 48.69% |
Net Margin | 3.78% | 4.76% | 0.55% | -1.02% | 4.51% | 6.47% | 7.51% | 8.87% | 8.48% | 9.03% |
Debt / Equity | 0.41x | 0.42x | 0.56x | 0.47x | 0.31x | 0.24x | 0.74x | 0.58x | 0.57x | 0.52x |
Interest Coverage | 5.64x | 5.78x | 1.17x | -0.32x | 11.25x | 14.04x | 8.23x | 5.10x | 6.97x | 10.74x |
FCF Conversion | 2.28x | 2.06x | 14.27x | -16.79x | 3.04x | 1.53x | 1.54x | 1.83x | 2.31x | 1.97x |
Revenue Growth | 20.54% | 21.28% | 12.7% | -3.11% | 11.5% | 7.09% | 9.24% | 7.89% | 11.66% | 11.17% |
Related:MMSI Dividend History·MMSI Revenue History·MMSI Price History·MMSI P/E History·MMSI Financial Ratios·MMSI Institutional Holders
MMSI SEC Filings & Documents
Merit Medical Systems, Inc. (MMSI) SEC filings — annual & quarterly reports (10-K, 10-Q)
MMSI Frequently Asked Questions
Merit Medical Systems, Inc. (MMSI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Merit Medical Systems, Inc. (MMSI) reported $1.54B in revenue for fiscal year 2025. This represents a 2954% increase from $50.5M in 1996.
Merit Medical Systems, Inc. (MMSI) grew revenue by 11.7% over the past year. This is steady growth.
Yes, Merit Medical Systems, Inc. (MMSI) is profitable, generating $139.3M in net income for fiscal year 2025 (8.5% net margin).
Dividend & Returns
Merit Medical Systems, Inc. (MMSI) has a return on equity (ROE) of 8.7%. This is below average, suggesting room for improvement.
Merit Medical Systems, Inc. (MMSI) generated $274.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.